EUZ vs. CRTX, BHL, ORM, AFP, PFP, REE, PYX, ALBA, ARK, and URU
Should you be buying Europa Metals stock or one of its competitors? The main competitors of Europa Metals include CRISM Therapeutics (CRTX), Bradda Head Lithium (BHL), Ormonde Mining (ORM), African Pioneer (AFP), Pathfinder Minerals (PFP), Altona Rare Earths (REE), PYX Resources (PYX), Alba Mineral Resources (ALBA), Arkle Resources (ARK), and URU Metals (URU). These companies are all part of the "other industrial metals & mining" industry.
Europa Metals vs. Its Competitors
Europa Metals (LON:EUZ) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.
In the previous week, CRISM Therapeutics had 1 more articles in the media than Europa Metals. MarketBeat recorded 1 mentions for CRISM Therapeutics and 0 mentions for Europa Metals. CRISM Therapeutics' average media sentiment score of 1.08 beat Europa Metals' score of 0.00 indicating that CRISM Therapeutics is being referred to more favorably in the news media.
1.1% of Europa Metals shares are held by institutional investors. Comparatively, 0.3% of CRISM Therapeutics shares are held by institutional investors. 79.9% of Europa Metals shares are held by insiders. Comparatively, 97.3% of CRISM Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Europa Metals has higher earnings, but lower revenue than CRISM Therapeutics. CRISM Therapeutics is trading at a lower price-to-earnings ratio than Europa Metals, indicating that it is currently the more affordable of the two stocks.
CRISM Therapeutics' return on equity of -13.12% beat Europa Metals' return on equity.
Europa Metals has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
Summary
CRISM Therapeutics beats Europa Metals on 6 of the 10 factors compared between the two stocks.
Get Europa Metals News Delivered to You Automatically
Sign up to receive the latest news and ratings for EUZ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EUZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Europa Metals Competitors List
Related Companies and Tools
This page (LON:EUZ) was last updated on 9/17/2025 by MarketBeat.com Staff
Free EUZ Stock Alerts